Published in J Am Heart Assoc on February 17, 2017
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med (2009) 13.42
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. JAMA Intern Med (2014) 5.09
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 4.39
Coronary revascularization trends in the United States, 2001-2008. JAMA (2011) 2.81
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ (2014) 2.62
Comparison of clinical and administrative data sources for hospital coronary artery bypass graft surgery report cards. Circulation (2007) 2.55
Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol (2010) 2.49
Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J (2014) 2.31
Trends in isolated coronary artery bypass grafting: an analysis of the Society of Thoracic Surgeons adult cardiac surgery database. J Thorac Cardiovasc Surg (2012) 2.09
Potential Impact of Modifiable Clinical Variables on Length of Stay After First-Time Cardiac Surgery. Ann Thorac Surg (2015) 1.99
Trends in coronary revascularization procedures among Medicare beneficiaries between 2008 and 2012. Circulation (2014) 1.49
First results of a national initiative to enable quality improvement of cardiovascular care by transparently reporting on patient-relevant outcomes. Eur J Cardiothorac Surg (2016) 1.40
Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population. Ann Thorac Surg (2016) 1.39
The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. Eur Heart J (2013) 0.94
Early discharge after coronary artery bypass graft surgery: are patients really going home earlier? J Thorac Cardiovasc Surg (2001) 0.93
Trend in percutaneous coronary intervention volume following the COURAGE and BARI-2D trials: insight from over 8.1 million percutaneous coronary interventions. Int J Cardiol (2015) 0.90
Myocardial Revascularization in New York State: Variations in the PCI-to-CABG Ratio and Their Implications. J Am Heart Assoc (2012) 0.81
The ACSIS Registry and primary angioplasty following coronary bypass surgery. Catheter Cardiovasc Interv (2011) 0.78
Population trends in rates of coronary revascularization. JAMA Intern Med (2015) 0.78
Transatlantic Editorial: a comparison between European and North American guidelines on myocardial revascularization. Eur J Cardiothorac Surg (2016) 0.77
PCI and CABG surgery in 2014: CABG surgery versus PCI in CAD--surgery strikes again! Nat Rev Cardiol (2015) 0.76
Enhancing the Value of Population-Based Risk Scores for Institutional-Level Use. Ann Thorac Surg (2016) 0.75
Pericardial covered stent for coronary perforations. Catheter Cardiovasc Interv (2015) 1.48
Valve Replacement in Patients with Carcinoid Heart Disease: Choosing the Right Valve at the Right Time. J Heart Valve Dis (2016) 0.77
Improved Outcomes With the Evolution of a Neoadjuvant Chemotherapy Approach to Right Heart Sarcoma. Ann Thorac Surg (2017) 0.75